Jona, Genome Insight, Covera Health
Jona, a Personalized Health Company Using AI to Analyze the Gut Microbiome, Launches with $5M in Funding
Jona, a technology company on a mission to reveal the relationship between the microbiome and health, today launched with $5 million in funding led by Breyer Capital and Meridian Street Capital.
Beginning today, consumers and providers can now purchase and use Jona's at-home microbiome profiling kit, which uses AI to analyze an individual's microbiome and deliver actionable insights that empower individuals to take a more proactive approach to their health in an era of rising chronic illness.
According to NIH research, 60-70 million Americans are affected by GI disorders1. In addition, the American Autoimmune Related Diseases Association (AARDA) reports that as many as 50 million Americans are living with an autoimmune disease costing billions of healthcare spending each year. Many of these individuals struggle to find a diagnosis, relieve symptoms, and find effective therapies. Jona's platform aims to equip these individuals with the latest scientific knowledge to discover root causes and develop effective treatment plans.
Jona is founded by Leo Grady, PhD, who is internationally recognized for his work to deliver AI in healthcare for nearly 20 years at pioneering bay area startups (HeartFlow), multinational medical companies (Siemens) and, most recently, as CEO of Paige.ai. He has built FDA approved AI applications for many areas of medicine, including radiology, cardiology and pathology that are now incorporated into standard care.
Jona, a Personalized Health Company Using AI to Analyze the Gut Microbiome, Launches with $5M in Funding
/PRNewswire/ -- Jona, a technology company on a mission to reveal the relationship between the microbiome and health, today launched with $5 million in funding...
AdaptX Raises $10M In Funding
AdaptX, a Seattle, WA-based self-serve clinical management solution company, raised $10M in funding.
The round was led by Cercano Management with participation from Memorial Hermann Health System and Morningside Ventures, as well as returning investors Founders’ Co-op, Fortson VC, Star Equity, and WRF Capital.
The company intends to use the funds to invest in its AI-driven Adaptive Clinical Management™ technology.
Led by Warren Ratliff, chief executive officer, and Dan Low, MD, chief medical officer, AdaptX provides self-serve solutions that empower clinical leaders to assess, improve, and manage care across patients, using data from their electronic medical records (EMRs). With it, clinicians rapidly adapt treatments and workflows, improving care for patients while delivering immediate return-on-investment (ROI) for their institutions. AdaptX’s AI-driven Mission Control Center™ empowers clinical leaders to quickly leverage their real-world data to assess performance, compare approaches, and adapt – across patients, teams, protocols, workflows, and facilities.
AdaptX Raises $10M In Funding
AdaptX, a Seattle, WA-based self-serve clinical management solution company, raised $10M in funding
Free Market Health Closes $20M Equity Financing
Free Market Health, a Pittsburgh, PA-based healthcare technology company, raised $20M in Equity funding.
The round was led by Questa Capital with participation from existing investors Alta Partners, Highmark Ventures, and 653 Investment Partners.
The company intends to use the funds to execute on business growth, launch channel partnership opportunities, and scale its care-driven marketplace platform.
Led by Joe Cardosi, Founder and CEO, Free Market Health partners with payers and specialty pharmacies of all sizes to streamline the specialty medication fulfillment process to ensure patients have access to lifesaving and life altering medications. Its marketplace streamlines the connection between patients and pharmacies to optimize cost and quality of care and empowers stakeholders to optimize resources and optimize opportunities with the goal of balancing the cost of care and the value that care provides.
The company’s platform currently manages more than 200,000 specialty drug claims annually.
Free Market Health Closes $20M Equity Financing
Free Market Health, a Pittsburgh, PA-based healthcare technology company, raised $20M in Equity funding
Genome Insight Raises $23M in Series B-2 Funding
Genome Insight, a San Diego, CA-based precision healthcare solutions company, raised $23M in Series B-2 funding.
The round was led by Samsung Venture Investment Corporation, Asan Foundation, SCL Group, and Ignite Innovation. Existing investors participated in this round.
The company intends to use the funds to support its pursuit of bringing whole-genome based precision diagnostics to routine clinical care.
Led by Young Seok Ju, Founder and CEO, Genome Insight is a precision healthcare solutions company promoting whole-genome technology for accurate diagnosis and personalized treatment for cancer and rare disease. Its mission is to improve how patients are diagnosed and treated, by unlocking the full potential of personalized genomic data. Earlier this year, the company announced the launch of CancerVision, a test that utilizes whole genome sequencing to offer precise, timely, and medical relevant information that assists in making individualized healthcare decision in cancer. CancerVision integrates advanced bioinformatics and computational techniques to determine whole-genome mutational profiles of individual cancer patients. The information is analyzed and curated for physicians in an easy-to-use format that captures the most relevant and actionable insights for each patient.
Genome Insight Raises $23M in Series B-2 Funding
Genome Insight, a San Diego, CA-based precision healthcare solutions company, raised $23M in Series B-2 funding
AI-enabled radiology performance platform Covera Health secures $50M
Covera Health, an AI-enabled clinical data analysis company focused on improving radiology readings, announced it secured an additional $50 million in Series C funding and finalized its acquisition of CoRead, which uses AI to flag medical errors on radiology examinations.
The funds add to the company's $25 million Series C round announced in 2021.
Insight Partners led the 2021 round and the current $50 million add-on, with $25 million being committed to Covera from the recent round today.
Former CoRead CEO Lawrence Ngo will join Covera Health as senior vice president of its quality assurance platform.
New York-based Covera Health uses AI and data analytics to help radiologists improve their accuracy and reduce misdiagnosis. Its data platform, the Radiology Centers of Excellence, is used by health plans and employers to guide patients toward high-quality radiology providers for their specific needs.
The company also works with payers to avoid unnecessary care and promote value-based payment.
